Direct admission to PCI center reduces mortality in STEMI

Direct admission to PCI center reduces mortality in STEMI
(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI), direct admission to a primary PCI center is associated with lower 12-month mortality, according to a study published online Feb. 15 in JACC: Cardiovascular Interventions.

Using data from a prospective nationwide registry, Damian Kawecki, M.D., Ph.D., from the Medical University of Silesia in Poland, and colleagues examined the impact of direct admission versus transfer via regional hospital to a PCI center on time delays and 12-month in STEMI patients. A total of 70,093 patients were eligible for analysis, of whom 56 percent were admitted directly to a PCI center.

The researchers found that direct admission correlated with a 44-minute shorter median symptoms-to-admission time (P < 0.001) and total ischemic time (228 versus 270 minutes; P < 0.001), higher left ventricle ejection fraction (47.5 versus 46.3 percent; P < 0.001), and lower propensity-matched 12-month mortality (9.6 versus 10.4 percent; P < 0.001). Direct admissions and shorter symptoms-to-admission time were significant predictors of lower 12-month mortality in propensity matched analysis (hazard ratios, 1.06 and 1.03, respectively).

"In a large, community-based cohort of patients with STEMI treated by PCI, direct admission to a primary PCI center was associated with lower 12-month mortality and should be preferred to transfer via a regional non-PCI-capable facility," the authors write.


Explore further

Renal transplant recipients often admitted with acute MI

More information: Full Text
Editorial

Copyright © 2017 HealthDay. All rights reserved.

Citation: Direct admission to PCI center reduces mortality in STEMI (2017, February 16) retrieved 20 May 2019 from https://medicalxpress.com/news/2017-02-admission-pci-center-mortality-stemi.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more